Skip to main content
Equibles
KROS $11.08 +0.41%
KROS logo
KROS · Keros Therapeutics, Inc.
Track KROS — free

Use KROS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$11.08 +0.05 (+0.41%)
Russell 2000 member Rebalance outlook locked
Market Cap
$218.69M
Shares
19.83M
All earnings calls

Earnings call · FY2023 Q2

Keros Therapeutics, Inc. (KROS) Q2 2023 Earnings Call

Concluded Aug 7, 2023
Aug 7, 2023 0 turns
Period
FY2023 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $0
Diluted EPS -$1.27
Net income -$37.51M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 7, 2023 10-Q report Filed Aug 7, 2023
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)